Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
1.250
-0.020 (-1.57%)
Aug 24, 2026, 9:51 AM EDT - Market open
Biodexa Pharmaceuticals Employees
Biodexa Pharmaceuticals had 11 employees as of December 31, 2025. The number of employees decreased by 2 or -15.38% compared to the previous year.
Employees
11
Change (1Y)
-2
Growth (1Y)
-15.38%
Revenue / Employee
n/a
Profits / Employee
-$781,109
Market Cap
1.29M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 11 | -2 | -15.38% |
| Dec 31, 2024 | 13 | -8 | -38.10% |
| Dec 31, 2023 | 21 | -6 | -22.22% |
| Dec 31, 2022 | 27 | 7 | 35.00% |
| Dec 31, 2021 | 20 | 2 | 11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Scinai Immunotherapeutics | 45 |
| HCW Biologics | 35 |
| Virax Biolabs Group | 26 |
| Silexion Therapeutics | 14 |
| Decoy Therapeutics | 11 |
| CDT Equity | 4 |
| Oragenics | 3 |
| Bone Biologics | 2 |
BDRX News
- 5 days ago - Biodexa recruits 87 of 168 subjects in Serenta Phase 3 eRapa polyposis trial - TheFly
- 5 days ago - Biodexa announces major milestone for its Serenta registrational Phase 3 trial in FAP - GlobeNewsWire
- 25 days ago - Biodexa Pharmaceuticals Registration statement: Registration filing - Filings
- 25 days ago - Result of General Meeting - GlobeNewsWire
- 26 days ago - Biodexa Initiates Support Activities for FAP Patients and Treatment Centers in France - GlobeNewsWire
- 5 weeks ago - Biodexa Pharmaceuticals Registration statement: Registration filing - Filings
- 7 weeks ago - Result of Annual General Meeting - GlobeNewsWire
- 7 weeks ago - Biodexa Pharmaceuticals announces pricing of $3.5M registered offering - TheFly